Main Article Content
Background: Type II Diabetes Mellitus (T2DM) is a considerable problem of global health, and finding new therapies for treating the disease continues. Recently, attention has been focused on vitamin D as a potential lowering agent of T2DM’s risk factors and its complications. The present work was conducted to determine the effect of vitamin D supplements on serum lipids, uric acid, C-Reactive Protein (CRP) and also Homeostatic Model Assessment of Insulin Resistance (HOMA-IR).
Materials and Methods: Sixty patients with T2DM as well as deficiency of vitamin D and referred to Rasoul-e-Akram Hospital in 2017 were selected by convenience sampling method. To begin the study, patients’ demographic information was required, so a questionnaire including age, waist circumference, sex, height, blood pressure and weight was provided. Patients with vitamin D3<30ng/ml were treated by a daily oral dose of 2000 unit of vitamin D supplementary for 12 weeks. Serum levels of triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), total cholesterol (TC), fasting blood sugar (FBS) and Hemoglobin A1C (HbA1C) were measured before and after vitamin D intake. Analysis of data was carried out through the Software Package SPSS Ver. 24.
Results: Sixty-five percent of study population (39 people) was composed of females. The mean value ± standard deviation (SD) amount of age and BMI were 46.8±8.9 years and 28.4±4.3 m2/kg. The mean ± SD systolic blood pressure (SBP), 19.3±122.8 mmHg and diastolic blood pressure (DBP) were 14.1±79 mmHg. The mean ± SD of vitamin D in patients was 11.4±4.5 ng / ml. The comparison of blood factors before and after treatment showed p value> 0.05.
Conclusions: Deficiency of vitamin D should be treated and prevented, but administration of this high-dose vitamin D supplements for prevention or improvement of T2DM has not been recommended yet. Our study showed a correlation between the vitamin D intake and decreased level of FBS and Uric Acid in diabetic patients.
Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinology and metabolism clinics of North America. 2014;43(1):205-32.
Alexender GM, David RB. Photosensitivity and other reactions to light. In: Longo DL FA, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editor. Harrison’s Principles of internal medicine. Vol 1. 18th ed: New York: Mc Graw Hill. 2012;440–47.
Robert MR, Paolo MS. Vitamin and trace mineral deficiency and excess. In: Longo DL FA, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editor. Harrison’s Principles of internal medicine. Vol 1. 18th ed: New York: Mc Graw Hill. 2012;594–605.
Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia. 2005;48(6):1038-50.
Lips P, Eekhoff M, van Schoor N, Oosterwerff M, de Jongh R, Krul-Poel Y, et al. Vitamin D and type 2 diabetes. The Journal of Steroid Biochemistry and Molecular Biology. 2017;173:2805.
Liefaard MC, Ligthart S, Vitezova A, Hofman A, Uitterlinden AG, Kiefte-de Jong JC, et al. Vitamin D and C-Reactive Protein: A Mendelian Randomization Study. PloS One. 2015;10(7):e0131740.
Nouri Saeidlou S, Vahabzadeh D, Babaei F, Vahabzadeh Z. Seasonal variations of vitamin D and its relation to lipid profile in Iranian children and adults. Journal of Health, Population and Nutrition. 2017; 36(1):21.
Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials. Lipids in Health and Disease. 2012;11:42.
Ponda MP, Huang X, Odeh MA, Breslow JL, Kaufman HW. Vitamin D may not improve lipid levels: A serial clinical laboratory data study. Circulation. 2012; 126(3):270-7.
de Abreu VG, Martins CJdM, de Oliveira PAC, Francischetti EA. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects. PloS One. 2017;12(7):e0180947-e.
Jehle S, Lardi A, Felix B, Hulter HN, Stettler C, Krapf R. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: A randomised, placebo-controlled, prospective pilot study. Swiss Medical Weekly. 2014;144:w13942.
Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A. Effects of calcium vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: A randomized controlled clinical trial. Diabetologia. 2014;57(10):2038-47.
Saedisomeolia A, Taheri E, Djalali M, Moghadam AM, Qorbani M. Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. Journal of Diabetes and Metabolic Disorders. 2014;13(1):7.
Cutillas-Marco E, Prosper AF, Grant WB, Morales-Suárez-Varela MM. Vitamin D status and hypercholesterolemia in Spanish general population. Dermato-Endocrinology. 2013;5(3):35862.
Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: A systematic review. European Journal of Clinical Nutrition. 2011;65(9):1005-15.
Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010;39(2):419-46.
Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome in U.S. adults. Diabetes Care. 2005;28(5):1228-30.
Oosterwerff MM, Eekhoff EM, Heymans MW, Lips P, Van Schoor NM. Serum 25 hydroxy vitamin D levels and the metabolic syndrome in older persons: A population-based study. Clinical Endocrinology. 2011; 75(5):608-13.
Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004; 27(12):2813-8.
Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. European Journal of Nutrition. 2663;89(0): 983-68.
Strobel F, Reusch J, Penna-Martinez M, Ramos-Lopez E, Klahold E, Klepzig C, et al. Effect of a randomised controlled vitamin D trial on insulin resistance and glucose metabolism in patients with type 2 diabetes mellitus. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2014;46(1):54-8.
Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care. 2006;29(10):2244-6.
Elkassaby S, Harrison LC, Mazzitelli N, Wentworth JM, Colman PG, Spelman T, et al. A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes. Diabetes Research and Clinical Practice. 2014;106(3): 576-82.
Sadiya A, Ahmed SM, Carlsson M, Tesfa Y, George M, Ali SH, et al. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: A randomized controlled double-blinded clinical trial. European Journal of Clinical Nutrition. 2015;69(6):707-11.